Prof. Dr. İLKAY TUĞBA ÜNEK

Yayın Ağı

Makaleler 71

1. SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab

Kolkiran N., ERDOĞAN A. P., ŞAHBAZLAR M., Tas S., Gokoz Dogu G., CANASLAN K., et al.

CURRENT ONCOLOGY , cilt.32, sa.10, 2025 (SCI-Expanded, Scopus)

2. Impact of Tumor Localization on Early Recurrence After Curative Resection in Pancreatic Ductal Adenocarcinoma

ÇALIŞKAN YILDIRIM E., ÜNEK İ. T., ÖZTOP İ., UZUN M., ÜNEK T., SAĞOL Ö.

Medicina (Lithuania) , cilt.61, sa.10, 2025 (SCI-Expanded, Scopus)

3. The Effect of HER2 Status on Gastric Cancer Survival and the Clinical Implications of the HER2-Low Definition: A Retrospective Study

Uzun M., Gokcek S., Kilinc M., EKİNCİ F., AVCI T., ERDOĞAN A. P., et al.

Medicina (Lithuania) , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus)

4. FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)

Kalem A., Kus T., Sahin T. K., DİZDAR Ö., Efil S. C., Sendur M. A. N., et al.

Cancers , cilt.17, sa.17, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Prognostic Impact of Glomerular Filtration Rate Decline on Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

Aktepe O. H., Arslan A. M., Yetginoglu O., Altas H., Sencan C., Akarca M. S., et al.

MEDICINA-LITHUANIA , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus)

6. Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

Kalem A., Kus T., Gokcek S., ÜNEK İ. T., Sahin T. K., DİZDAR Ö., et al.

Journal of Clinical Medicine , cilt.14, sa.16, 2025 (SCI-Expanded, Scopus)

7. Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

Güren A. K., Polat H., Çoban E., Çerme E., Kahveci G. B., Geçgel A., et al.

ANNALS OF SAUDI MEDICINE , cilt.45, sa.4, ss.249-255, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Association of Systemic Inflammatory Response Index and Prognostic Nutritional Index Scores with Sarcopenia in Patients with Metastatic Gastric Cancer

Kanbur B., ÜNEK İ. T., Uzun M., ÖZTÜRK C., YAROL R. C., BALCI A.

Medicina (Lithuania) , cilt.61, sa.5, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

Aktepe O. H., Erdemır A. G., Yildirim E. C., Demirciler E., Ulasli T., Guven D. C., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.14, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

Ceylan F., Aktürk Esen S., Ünal O. Ü., Aslan F., Onur İ. D., Ateş Ö., et al.

Medicina (Lithuania) , cilt.61, sa.5, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. THE PROGNOSTIC ROLE OF SYSTEMIC INFLAMMATORY RESPONSE INDEX IN SURGICALLY TREATED PANCREATIC DUCTAL ADENOCARCINOMA PATIENTS

Yildirim E. C., Gokcek S., Uzun M., Ozalp F. R., ÜNEK T., SAĞOL Ö., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.9, sa.3, ss.612-618, 2025 (ESCI, TRDizin)

12. Inflammation-Associated Long Non-Coding RNAs (lncRNAs) in Chronic Viral Hepatitis-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.41, sa.1, ss.1-8, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

13. lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.40, sa.2, ss.101-108, 2024 (ESCI, Scopus, TRDizin)

14. INVESTIGATION OF CANCER STEM CELL SURFACE MARKERS IN THE TUMOR TISSUES OF PATIENTS WHO HAD LIVER TRANSPLANTATION DUE TO HEPATOCELLULAR CANCER AND EVALUATION OF THE EFFECT OF THESE MARKERS ON PROGNOSIS

Egeli T., Unek T., Aysal Ağalar A., Ünek İ. T., Agalar C., Özbilgin M., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.8, sa.3, ss.704-709, 2024 (ESCI) Sürdürülebilir Kalkınma

15. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

AKYILDIZ A., Guven D. C., Ozluk A. A., Ismayilov R., Mutlu E., Unal O. U., et al.

Medicine , cilt.102, sa.45, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.

The oncologist , cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded, Scopus)

17. Factors Predicting Response in Breast Cancer Receiving Neoadjuvant Therapy and the Role of Ki67 Labeling Index

Ekinci F., Uzun M., Demir B., Ünek İ. T., Erdoğan A. P.

Journal of College of Physicians and Surgeons Pakistan , cilt.33, sa.08, ss.872-878, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Association of Serum Hepatocyte Growth Factor Level with Systemic Inflammatory Biomarkers in Patients with Pancreatobiliary Cancer

Ünek İ. T., Öztop İ., Başbınar Y., Ünek T., Leblebici A., Çakıroğlu E., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.34, sa.5, ss.568-575, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

19. Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer

Akagunduz B., Guven D. C., Ozer M., Okten I. N., Atag E., Unek İ. T., et al.

JOURNAL OF GERIATRIC ONCOLOGY , cilt.14, sa.2, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer

Ünek İ. T., Öztop İ., Başbınar Y., Ünek T., Leblebici A., Karaca C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.34, sa.3, ss.278-286, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

21. Does Mammographic Density Predict Pathological Complete Response in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy?

UZUN M., Kurtuluş E., ÇALIŞKAN YILDIRIM E., ÜNEK İ. T., SEMİZ H. S., ELLEZ H. İ., et al.

Eurasian Journal of Medical Investigation , cilt.7, sa.2, 2023 (TRDizin)

22. The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma

Aysal A., Agalar C., Cagaptay S., Safak T., Egeli T., Ozbilgin M., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.38, sa.3, ss.284-291, 2022 (ESCI, Scopus, TRDizin)

23. Peritumoral histopathologic findings in patients with chronic viral hepatitis-associated hepatocellular carcinoma

PEHLİVANOĞLU B., AYSAL AĞALAR A., AĞALAR C., EGELİ T., Ozbilgin M., ÜNEK T., et al.

APMIS , cilt.130, sa.6, ss.346-356, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Clinical Significance of the Immune Prognostic Index in Patients with Endometrial Carcinoma

ERGÜN B., ÜNEK İ. T., SEMİZ H. S., Saatli B., Alicikus Z. A., BARLIK F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.222-230, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

25. Combination of gemcitabine, infusional 5-fluorouracil and high-dose folinic acid (GEMFUFOL) as adjuvant chemotherapy in resected pancreatic cancer

ÜNEK İ. T., ÖZTOP İ., Koca D., ÜNEK T., AYSAL AĞALAR A., GÜÇ Z. G., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2496-2504, 2021 (SCI-Expanded, Scopus)

26. PROGNOSTIC FACTORS AND PROGNOSTIC INDEX FOR PATIENTS WITH ADVANCED PANCREATIC CANCER Single Center Experience and Review of the Literature

ÜNEK İ. T., ÜNEK T., KOCA D., AKMAN T., SALMAN T., ELLİDOKUZ H., et al.

JOURNAL OF B.U.ON. , cilt.26, sa.6, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Metastatik Mide ve Kolorektal Kanserli Hastalarda Kemoterapinin Yaşam Kalitesi Üzerine Etkisi

ÇAKIN ÜNNÜ S., ÜNEK İ. T., TOPALOĞLU Ö.

İzmir Tepecik Eğitim Hastanesi Dergisi , cilt.31, sa.2, ss.209-218, 2021 (TRDizin) Sürdürülebilir Kalkınma

28. The Prognostic Significance of Modified Lymph Node Ratio and LODDS in HER-2(+) Breast Cancer

Özkan F., Unek İ. T., Ünal O. Ü., Emiroğlu M., Leblebici A., Ellidokuz H., et al.

The journal of Tepecik Education and Research Hospital , cilt.31, ss.253-260, 2021 (TRDizin)

29. Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received177Lu PSMA I&T therapy

Bülbül O., ÜNEK İ. T., KEFİ A., TUNA E. B., BEKİŞ R.

Hellenic Journal of Nuclear Medicine , cilt.23, sa.3, ss.229-239, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received ¹⁷⁷Lu PSMA I&T therapy

Bulbul O., ÜNEK İ. T., KEFİ A., TUNA E. B., BEKİŞ R.

HELLENIC JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.3, ss.229-239, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. The Role of Log Odds of Positive Lymph Nodes in Predicting the Survival after Resection for Ampullary Adenocarcinoma.

AĞALAR C., AYSAL AĞALAR A., ÜNEK T., EGELİ T., Ozbilgin M., Akturk N., et al.

Pathology oncology research : POR , cilt.26, sa.1, ss.467-473, 2020 (SCI-Expanded, Scopus)

32. De Novo Malignancies After Liver Transplantation: A Single Institution Experience

EGELİ T., ÜNEK T., Ozbilgin M., AĞALAR C., Derici S., AKARSU M., et al.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , cilt.17, sa.1, ss.74-78, 2019 (SCI-Expanded, Scopus)

33. Solid Organ Transplantasyonu ve Malignite

ÜNEK İ. T., EGELİ T.

Türkiye Klinikleri , cilt.10, sa.2, ss.239-251, 2017 (Hakemli Dergi)

34. Tıbbi Onkologlar Tarafından Yerleştirilen Santral Venöz Port Kataterlerinin Değerlendirilmesi: Tek Merkez Deneyimi

Salman T., Türkyılmaz D., Yavuzşen T., Somalı I., Alacacıoğlu A., Koca D., et al.

ACTA ONCOLOGICA TURCICA , cilt.49, sa.2, ss.102-110, 2016 (TRDizin)

35. Epstein Barr Virus Associated Lymphoepithelioma Like Carcinoma of the Esophagogastric Junction and Stomach A Case Report and Review of the Literature

ATAĞ E., KAZAZ S. N., SEMİZ H. S., ÜNEK İ. T., SARIOĞLU S., YAVUZŞEN T.

Journal of Clinical Experimental Oncology , cilt.5, sa.06, 2016 (Hakemli Dergi)

36. The association of clinicopathological features and survival in colorectal cancer patients with kras mutation status

Akman T., ÖZTOP İ., BAŞBINAR Y., ÜNEK İ. T., DEMİR N., ELLİDOKUZ H., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.12, sa.1, ss.96-102, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

TURAN N., BENEKLİ M., Unal O. U., ÜNEK İ. T., Tastekin D., DANE F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded, Scopus)

38. Adulthood hepatoblastoma

Akman T., Oktan M. A., ÜNEK İ. T., ÜNEK T., ÖZTOP İ., YAVUZŞEN T., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.26, sa.1, ss.73-74, 2015 (SCI-Expanded, Scopus, TRDizin)

39. Kolorektal Kanserli Hastalarda Karaciğer Metastazına Yaklaşım

Ünek İ. T.

Turkiye Klinikleri J Medical Oncology-Special Topics , cilt.8, sa.1, ss.24-37, 2015 (Hakemli Dergi)

40. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)

Inal A., Kos F. T., Algin E., Yildiz R., Berk V., ÜNEK İ. T., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.19, sa.2, ss.125-129, 2015 (ESCI, Scopus)

41. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study

Salman T., KAZAZ S. N., Varol U., Oflazoglu U., ÜNEK İ. T., KÜÇÜKZEYBEK Y., et al.

CHEMOTHERAPY , cilt.61, sa.6, ss.281-286, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases A Case Report and Review of the Literature

Cokmert S., Demir L., Doganay L., Demir N., Kocacelebi K., ÜNEK İ. T., et al.

WEST INDIAN MEDICAL JOURNAL , cilt.63, sa.6, ss.667-672, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Clitoris metastasis from a retroperitoneal leiomyosarcoma A case report

ÇOKMERT S., DEMİR L., AKYOL M., BAYOĞLU İ. V., CAN A., ÜNEK İ. T., et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY , cilt.5, sa.1, ss.28, 2014 (Scopus)

44. Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

Akman T., ÖZTOP İ., ÜNEK İ. T., Koca D., Unal O. U., Salman T., et al.

CHEMOTHERAPY , cilt.60, sa.4, ss.228-238, 2014 (SCI-Expanded, Scopus)

45. Malign Recurrence of Primary Chest Wall Hemangiopericytoma in the Lung after Four Years: A Case Report and Review of the Literature

Akman T., Alacacioglu A., Dolek D., Unek T., GÜREL D., Yilmaz A. U., et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2014, 2014 (ESCI)

46. Impact of Accompanying Comorbidities on Survival in Patients with Stage IIIB- IV Non-Small-Cell Lung Cancer

Demirpence M., Akman T., ÖZTOP İ., ÜNEK İ. T., YAVUZŞEN T., Yilmaz A. U.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.223-232, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

47. CD40 Expression In Pancreatic Cancer

ÜNEK T., ÜNEK İ. T., AYSAL AĞALAR A., SAĞOL Ö., ELLİDOKUZ H., Ertener O., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.128, ss.2085-2093, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma

ÜNEK İ. T., Akman T., ÖZTOP İ., Unal O. U., Salman T., Yilmaz U.

GASTRIC CANCER , cilt.16, sa.3, ss.428-434, 2013 (SCI-Expanded, Scopus)

49. Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Demirci U., Tufan G., Aktas B., Balakan O., ALACACIOĞLU A., DANE F., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.139, sa.5, ss.829-835, 2013 (SCI-Expanded, Scopus)

50. Increased 18F FDG uptake in an unusual localization of giant cell tumor of the tendon sheath.

Demir Y., ÜNEK İ. T., Tuncel A. S., Karatosun V. A., Ozkal S., ÇAPA KAYA G.

Revista espanola de medicina nuclear e imagen molecular , cilt.32, sa.3, ss.205-6, 2013 (SCI-Expanded, Scopus)

51. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy

Bilici A., Salman T., Ustaalioglu B. B. O., Unek T., Seker M., ALİUSTAOĞLU M., et al.

JOURNAL OF SURGICAL RESEARCH , cilt.180, sa.1, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Two-Week Combination Chemotherapy with Gemcitabine, High-Dose Folinic Acid and 5 Fluorouracil (GEMFUFOL) as First-Line Treatment of Metastatic Biliary Tract Cancers

Unal O. U., ÖZTOP İ., ÜNEK İ. T., Yilmaz A. U.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.9, ss.5263-5267, 2013 (SCI-Expanded, Scopus)

53. Long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study

Inal A., Ciltas A., Yildiz R., Berk V., Kos F. T., DANE F., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.5, ss.1841-1844, 2012 (SCI-Expanded, Scopus)

54. Bimonthly Regimen of High-Dose Leucovorin, Infusional 5-Fluorouracil, Epirubicin and Cisplatin (Modified ECF) as Adjuvant Chemotherapy in Resected Gastric Adenocarcinoma

ÜNEK İ. T., ÜNEK T., ÖZTOP İ., Akman T., Atilla K., ELLİDOKUZ H., et al.

CHEMOTHERAPY , cilt.58, sa.3, ss.233-240, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study

Inal A., Kos F. T., Algin E., Yildiz R., Dikiltas M., ÜNEK İ. T., et al.

NEOPLASMA , cilt.59, sa.3, ss.297-301, 2012 (SCI-Expanded, Scopus)

56. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study

Inal A., Kos F. T., Algin E., Yildiz R., Berk V., ÜNEK İ. T., et al.

JOURNAL OF BUON , cilt.17, sa.1, ss.102-105, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Clinical and Electrocardiography Changes in Patients Treated with Capecitabine

Koca D., Salman T., ÜNEK İ. T., ÖZTOP İ., ELLİDOKUZ H., Eren M., et al.

CHEMOTHERAPY , cilt.57, sa.5, ss.381-387, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Alkış N., Demirci U., Benekli M., Yılmaz U., Işıkdoğan A., Sevinç A., et al.

JOURNAL OF B.U.ON. , cilt.16, sa.1, ss.80-83, 2011 (SCI-Expanded, Scopus)

59. Adrenalectomy for Isolated Metastasis in Five Patients with Lung Cancer: Single Centre Experience and Review of the Literature

ÜNEK İ. T., KOÇDOR M. A., SEVİNÇ A. İ., Onen A., ÖZDOĞAN Ö., ÖZTOP İ., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.21, sa.4, ss.230-240, 2011 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

60. Ayaktan tedavi gören kanser hastalarının kemoterapi sırasında uğraşı seçimleri: Anket çalışmasının sonuçları

Çokmert S., Yavuzşen T., Ünek İ. T.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.2, sa.1, ss.31-36, 2011 (Hakemli Dergi) Sürdürülebilir Kalkınma

61. The Levels of Soluble CD40 Ligand and C-Reactive Protein in Normal Weight, Overweight and Obese People

ÜNEK İ. T., BAYRAKTAR F., Solmaz D., ELLİDOKUZ H., Sisman A., YÜKSEL F., et al.

CLINICAL MEDICINE & RESEARCH , cilt.8, sa.2, ss.89-95, 2010 (ESCI, Scopus)

62. Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer

Oztop İ., Alacacioglu A., ÜNEK İ. T., Tarhan O., Somali I., Cokmert S., et al.

JOURNAL OF BUON , cilt.15, sa.3, ss.462-469, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome

ÜNEK İ. T., BAYRAKTAR F., Solmaz D., ELLİDOKUZ H., YÜKSEL F., Sisman A., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.59, sa.3, ss.305-313, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: Case report

Demirkan B., ÜNEK İ. T., Eriksson B., AKARSU M., Durak H., SAĞOL Ö., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.20, sa.3, ss.214-219, 2009 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

65. Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor

ÜNEK İ. T., ÇELTİK A., Yener S., YAVUZŞEN T., Alacacioglu A., Cokmert S., et al.

JOURNAL OF BUON , cilt.14, sa.1, ss.135-138, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Epidemiology and survival of hepatocellular carcinoma in Turkey: Outcome of multicenter study

Alacacioglu A., Somali I., Simsek I., Astarcioglu I., ÖZKAN M., Camci C., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.10, ss.683-688, 2008 (SCI-Expanded, Scopus)

67. Synchronous appearance of male breast cancer and pancreatic cancer 15 years after the diagnosis of testicular cancer - report of a case

ÜNEK İ. T., Alacacioglu A., Tarhan O., Sevinc A. I., Oztop İ., Sagol Ö., et al.

JOURNAL OF BUON , cilt.13, sa.3, ss.421-424, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Gastric carcinoma during pregnancy: Report of a case

ÜNEK İ. T., ÇELTİK A., Alacacioglu A., Cokmert S., YAVUZŞEN T., Dogan N. S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

69. Reflex sympathetic dystrophy syndrome due to arteriovenous fistula

ÜNEK İ. T., Birlik M., ÇAVDAR C., Ersoy R., ÖNEN F., Celik A., et al.

Hemodialysis International , cilt.9, sa.4, ss.344-348, 2005 (SCI-Expanded, Scopus)

70. Weil Hastalığı: Aseptik Menenjit, Akut Böbrek Yetmezliği ve Şiddetli Üst Gastrointestinal Sistem Kanaması ile Seyreden Bir Olgu Sunumu

ÜNEK İ. T., SAGLAM F., DEMIR U., BIBEROGLU K.

İç Hastalıkları Dergisi (:Dahili Tıp Bilimleri Dergisi ) , 2005 (TRDizin)

71. Paraspinal Muscle Abscess Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In a Patient With Chronic Renal Failure

CAVDAR C., ÜNEK İ. T., NADERI S., YENICERIOGLU Y., ERSOY R., CAMSARI T.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , 2002 (TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. İnce bağırsak lokalizasyonlu berrak hücreli karsinoma

SALMAN T., ALACACIOĞLU A., AKMAN T., ÜNAL O. Ü., ÜNEK İ. T., SEVGEN Z., et al.

II.Nadir Tümörler Sempozyumu, Türkiye, 27 Şubat - 01 Mart 2015

Kitaplar 2

1. Pankreas kanserleri

ÜNEK İ. T.

Geriatrik Onkoloji, Karaoğlu A, Yavuzşen T, Editör, Nobel Tıp Kitabevleri, İstanbul, ss.263-268, 2021

2. Hepatosellüler Karsinomda Karaciğer Transplantasyonu Sonrası Adjuvan Tedavi

ÜNEK İ. T., ÖZTOP İ.

Karaciğer Transplantasyonu, Sevda Özkardeşler, İdil Tekin, Tarkan Ünek, Editör, Ven Kitabevi, İzmir, ss.697-703, 2015

Diğer Yayınlar 1

1. NADİR GÖRÜLEN EXON 18 (G719A) VE EXON 20 (S768I) MUTASYONU İLE İZLENEN AKCİĞER ADENOKANSERİ;VAKA TAKDİMİ

Kanbur B., Kılınç M., Kantar R., Uzun M., Ünek İ. T.

Sunum, ss.270-271, 2022 Sürdürülebilir Kalkınma

Metrikler

Yayın

221

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

398

H-İndeks (WoS)

Atıf (Scopus)

445

H-İndeks (Scopus)

Atıf (Scholar)

133

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler